Evidence map›Paper›PMID 34331856›Full record

ArticleCancer cell2021

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.

Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, Patrick W Johnson, Louis J DeGennaro, Gwen L Nichols

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 164 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 14 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 14 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Guideline
  13. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Lee M GreenbergerThe Leukemia & Lymphoma Society, Rye Brook, NY, USA. Electronic address: lee.greenberger@lls.org.
Larry A SaltzmanThe Leukemia & Lymphoma Society, Rye Brook, NY, USA.
Jonathon W SenefeldDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
Patrick W JohnsonDepartment of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
Louis J DeGennaroThe Leukemia & Lymphoma Society, Rye Brook, NY, USA.
Gwen L NicholsThe Leukemia & Lymphoma Society, Rye Brook, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Hematologic NeoplasmsAntibody FormationCOVID-19 VaccinesHumansSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID34331856
PMCPMC8295014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.